Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Apr 9, 2020

Total Value: $470M (100.0% shares, 0.0% debt)

Holdings (55)

XBI SPDR SERIES TRUST 10.2%
Value $47.94M Shares 500,000 Share Price $95.87 Est. Cost/Share — Unrealized @ Report Date —
SRPT SAREPTA THERAPEUTICS INC 7.2%
Value $33.92M Shares 210,000 Share Price $161.51 * Est. Cost/Share $78.35 Unrealized @ Report Date +74.5%
PTCT PTC THERAPEUTICS INC 5.0%
Value $23.5M Shares 500,000 Share Price $47.00 * Est. Cost/Share $29.45 Unrealized @ Report Date +40.5%
— MIRATI THERAPEUTICS INC 4.4%
Value $20.5M Shares 435,300 Share Price $47.10 Est. Cost/Share $33.00 Unrealized @ Report Date —
— ENDOCYTE INC 4.2%
Value $19.54M Shares 1,100,000 Share Price $17.76 Est. Cost/Share $13.82 Unrealized @ Report Date —
— IMMUNOMEDICS INC 3.9%
Value $18.41M Shares 883,823 Share Price $20.83 Est. Cost/Share $8.35 Unrealized @ Report Date —
— TESARO INC 3.7%
Value $17.55M Shares 450,000 Share Price $39.01 Est. Cost/Share $39.01 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 3.6%
Value $16.79M Shares 1,100,000 Share Price $15.26 Est. Cost/Share $11.67 Unrealized @ Report Date —
ASND ASCENDIS PHARMA A S 3.4%
Value $15.94M Shares 225,000 Share Price $70.86 Est. Cost/Share $49.12 Unrealized @ Report Date —
ALNY ALNYLAM PHARMACEUTICALS INC 3.3%
Value $15.32M Shares 175,000 Share Price $87.52 * Est. Cost/Share $99.19 Unrealized @ Report Date +1.4%
— MIRATI THERAPEUTICS INC 3.0%
Value $14.13M Shares 300,000 Share Price $47.10 Est. Cost/Share $33.00 Unrealized @ Report Date —
FXF INVESCO CURNCYSHS SWISS FRAN 2.6%
Value $12.27M Shares 128,700 Share Price $95.31 Est. Cost/Share $95.31 Unrealized @ Report Date —
— ASSEMBLY BIOSCIENCES INC 2.6%
Value $12.07M Shares 325,000 Share Price $37.14 Est. Cost/Share $43.22 Unrealized @ Report Date —
— BLUEBIRD BIO INC 2.3%
Value $10.95M Shares 75,000 Share Price $146.00 Est. Cost/Share $156.95 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 2.2%
Value $10.38M Shares 500,000 Share Price $20.76 * Est. Cost/Share $25.20 Unrealized @ Report Date -37.6%
ACAD ACADIA PHARMACEUTICALS INC 2.2%
Value $10.38M Shares 500,000 Share Price $20.76 * Est. Cost/Share $25.20 Unrealized @ Report Date -37.6%
— RETROPHIN INC 2.1%
Value $10.06M Shares 350,000 Share Price $28.73 Est. Cost/Share $28.73 Unrealized @ Report Date —
— ZOGENIX INC 2.1%
Value $9.92M Shares 200,000 Share Price $49.60 Est. Cost/Share $49.60 Unrealized @ Report Date —
RCKT ROCKET PHARMACEUTICALS INC 2.1%
Value $9.848M Shares 400,000 Share Price $24.62 * Est. Cost/Share $16.98 Unrealized @ Report Date +27.7%
— OBSEVA SA 2.1%
Value $9.646M Shares 535,000 Share Price $18.03 Est. Cost/Share $11.85 Unrealized @ Report Date —
ARGX ARGENX SE 2.0%
Value $9.48M Shares 125,000 Share Price $75.84 Est. Cost/Share $21.52 Unrealized @ Report Date —
— ZAFGEN INC 1.9%
Value $8.768M Shares 750,000 Share Price $11.69 Est. Cost/Share $11.49 Unrealized @ Report Date —
— PORTOLA PHARMACEUTICALS INC 1.7%
Value $7.989M Shares 300,000 Share Price $26.63 Est. Cost/Share $26.63 Unrealized @ Report Date —
— TRICIDA INC 1.6%
Value $7.638M Shares 250,000 Share Price $30.55 Est. Cost/Share $30.07 Unrealized @ Report Date —
— BIOHAVEN PHARMACTL HLDG CO L 1.6%
Value $7.51M Shares 200,000 Share Price $37.55 Est. Cost/Share $37.55 Unrealized @ Report Date —
VRAYQ VIEWRAY INC 1.5%
Value $7.02M Shares 750,000 Share Price $9.36 * Est. Cost/Share $6.99 Unrealized @ Report Date +40.7%
— KADMON HLDGS INC 1.4%
Value $6.68M Shares 2,000,000 Share Price $3.34 Est. Cost/Share $3.85 Unrealized @ Report Date —
ANAB ANAPTYSBIO INC 1.3%
Value $5.986M Shares 60,000 Share Price $99.77 * Est. Cost/Share $87.53 Unrealized @ Report Date -5.2%
— GLYCOMIMETICS INC 1.2%
Value $5.76M Shares 400,000 Share Price $14.40 Est. Cost/Share $16.19 Unrealized @ Report Date —
— GLOBAL BLOOD THERAPEUTICS IN 1.2%
Value $5.7M Shares 150,000 Share Price $38.00 Est. Cost/Share $45.20 Unrealized @ Report Date —
KALV KALVISTA PHARMACEUTICALS INC 1.1%
Value $4.975M Shares 225,000 Share Price $22.11 * Est. Cost/Share $13.52 Unrealized @ Report Date 0.0%
ALNY ALNYLAM PHARMACEUTICALS INC 0.9%
Value $4.376M Shares 50,000 Share Price $87.52 * Est. Cost/Share $99.19 Unrealized @ Report Date +1.4%
— BIODELIVERY SCIENCES INTL IN 0.9%
Value $4.2M Shares 1,500,000 Share Price $2.80 Est. Cost/Share $2.94 Unrealized @ Report Date —
KURA KURA ONCOLOGY INC 0.9%
Value $4.025M Shares 230,000 Share Price $17.50 * Est. Cost/Share $16.94 Unrealized @ Report Date +13.2%
BCRX BIOCRYST PHARMACEUTICALS 0.8%
Value $3.815M Shares 500,000 Share Price $7.63 * Est. Cost/Share $6.72 Unrealized @ Report Date 0.0%
UROV UROVANT SCIENCES LTD 0.8%
Value $3.6M Shares 300,000 Share Price $12.00 Est. Cost/Share $12.00 Unrealized @ Report Date —
— RADIUS HEALTH INC 0.8%
Value $3.56M Shares 200,000 Share Price $17.80 Est. Cost/Share $17.80 Unrealized @ Report Date —
— ALLAKOS INC 0.7%
Value $3.374M Shares 75,000 Share Price $44.99 Est. Cost/Share $44.99 Unrealized @ Report Date —
APLS APELLIS PHARMACEUTICALS INC 0.7%
Value $3.289M Shares 185,000 Share Price $17.78 * Est. Cost/Share $22.98 Unrealized @ Report Date -19.5%
MDGL MADRIGAL PHARMACEUTICALS INC 0.6%
Value $3.041M Shares 14,200 Share Price $214.15 * Est. Cost/Share $175.60 Unrealized @ Report Date +42.9%
ARVN ARVINAS INC 0.6%
Value $2.952M Shares 175,000 Share Price $16.87 * Est. Cost/Share $16.46 Unrealized @ Report Date 0.0%
— GENOCEA BIOSCIENCES INC 0.6%
Value $2.748M Shares 3,525,000 Share Price $0.78 Est. Cost/Share $0.86 Unrealized @ Report Date —
— NEOS THERAPEUTICS INC 0.5%
Value $2.341M Shares 482,600 Share Price $4.85 Est. Cost/Share $7.80 Unrealized @ Report Date —
— CATALYST BIOSCIENCES INC 0.5%
Value $2.156M Shares 200,000 Share Price $10.78 Est. Cost/Share $25.80 Unrealized @ Report Date —
— AVADEL PHARMACEUTICALS PLC 0.4%
Value $1.976M Shares 450,000 Share Price $4.39 Est. Cost/Share $7.29 Unrealized @ Report Date —
— AQUINOX PHARMACEUTICALS INC 0.3%
Value $1.465M Shares 500,000 Share Price $2.93 Est. Cost/Share $2.93 Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 0.3%
Value $1.342M Shares 9,500 Share Price $141.26 Est. Cost/Share $141.26 Unrealized @ Report Date —
FATE FATE THERAPEUTICS INC 0.3%
Value $1.222M Shares 75,000 Share Price $16.29 * Est. Cost/Share $11.83 Unrealized @ Report Date 0.0%
— GRITSTONE ONCOLOGY INC 0.2%
Value $1.068M Shares 75,000 Share Price $14.24 Est. Cost/Share $14.24 Unrealized @ Report Date —
— EDGE THERAPEUTICS INC 0.2%
Value $820K Shares 1,000,000 Share Price $0.82 Est. Cost/Share $0.98 Unrealized @ Report Date —
— SPECTRUM PHARMACEUTICALS INC 0.2%
Value $793K Shares 47,200 Share Price $16.80 Est. Cost/Share $19.36 Unrealized @ Report Date —
INSM INSMED INC 0.1%
Value $526K Shares 26,000 Share Price $20.23 * Est. Cost/Share $22.61 Unrealized @ Report Date 0.0%
— MOTUS GI HLDGS INC 0.1%
Value $510K Shares 100,000 Share Price $5.10 Est. Cost/Share $4.48 Unrealized @ Report Date —
— GLOBAL BLOOD THERAPEUTICS IN 0.1%
Value $456K Shares 12,000 Share Price $38.00 Est. Cost/Share $45.20 Unrealized @ Report Date —
TGTX TG THERAPEUTICS INC 0.1%
Value $255K Shares 45,500 Share Price $5.60 * Est. Cost/Share $12.78 Unrealized @ Report Date -10.6%